Cargando…

Pattern evolution of antidepressants and benzodiazepines use in a cohort

OBJECTIVE: In recent decades there has been an increase in the use of antidepressants (AD) and a decrease in the use of benzodiazepines (BDZ). Prevalence, cumulative incidence, and factors associated with the incidence of AD and BDZ use in a Brazilian population were estimated in this article. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcantara, Geisy de Carvalho, Coutinho, Evandro Silva Freire, Faerstein, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112744/
https://www.ncbi.nlm.nih.gov/pubmed/32294666
http://dx.doi.org/10.11606/s1518-8787.2020054001887
_version_ 1783513533428793344
author Alcantara, Geisy de Carvalho
Coutinho, Evandro Silva Freire
Faerstein, Eduardo
author_facet Alcantara, Geisy de Carvalho
Coutinho, Evandro Silva Freire
Faerstein, Eduardo
author_sort Alcantara, Geisy de Carvalho
collection PubMed
description OBJECTIVE: In recent decades there has been an increase in the use of antidepressants (AD) and a decrease in the use of benzodiazepines (BDZ). Prevalence, cumulative incidence, and factors associated with the incidence of AD and BDZ use in a Brazilian population were estimated in this article. METHODS: Data were collected with a self-administered questionnaire in a cohort of employees from a university in Rio de Janeiro. The prevalence of the use of AD and BDZ was calculated for 1999 (4,030), 2001 (3,574), 2006-07 (3,058), and 2012 (2,933). The cumulative incidences of the use of AD and BDZ between 1999 and 2007 were estimated by the Poisson models with robust variance estimates. RESULTS: In 1999, the prevalence of the use of AD and BDZ were 1.4% (95%CI: 1.1–1.8) and 4.7% (95%CI: 4.1–5.4), respectively; in 2012, they were 5.4% (95%CI: 5.5–6.2) and 6.8% (95%CI: 6.0–7.8). The incidence of use, between 1999 and 2007, was 4.9% (95%CI: 4.2–5.7) for AD and 8.3% (95%CI: 7.3–9.3) for BDZ. The incidences of AD and BDZ use were higher among women and participants with a positive General Health Questionnaire. CONCLUSION: In this population, the increase in the use of AD was not accompanied by a decrease in the use of BDZ, showing the prescriptions for psychotropic medication do not follow the currently recommended guidelines for treatment of common mental health disorders.
format Online
Article
Text
id pubmed-7112744
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-71127442020-04-10 Pattern evolution of antidepressants and benzodiazepines use in a cohort Alcantara, Geisy de Carvalho Coutinho, Evandro Silva Freire Faerstein, Eduardo Rev Saude Publica Original Article OBJECTIVE: In recent decades there has been an increase in the use of antidepressants (AD) and a decrease in the use of benzodiazepines (BDZ). Prevalence, cumulative incidence, and factors associated with the incidence of AD and BDZ use in a Brazilian population were estimated in this article. METHODS: Data were collected with a self-administered questionnaire in a cohort of employees from a university in Rio de Janeiro. The prevalence of the use of AD and BDZ was calculated for 1999 (4,030), 2001 (3,574), 2006-07 (3,058), and 2012 (2,933). The cumulative incidences of the use of AD and BDZ between 1999 and 2007 were estimated by the Poisson models with robust variance estimates. RESULTS: In 1999, the prevalence of the use of AD and BDZ were 1.4% (95%CI: 1.1–1.8) and 4.7% (95%CI: 4.1–5.4), respectively; in 2012, they were 5.4% (95%CI: 5.5–6.2) and 6.8% (95%CI: 6.0–7.8). The incidence of use, between 1999 and 2007, was 4.9% (95%CI: 4.2–5.7) for AD and 8.3% (95%CI: 7.3–9.3) for BDZ. The incidences of AD and BDZ use were higher among women and participants with a positive General Health Questionnaire. CONCLUSION: In this population, the increase in the use of AD was not accompanied by a decrease in the use of BDZ, showing the prescriptions for psychotropic medication do not follow the currently recommended guidelines for treatment of common mental health disorders. Faculdade de Saúde Pública da Universidade de São Paulo 2020-03-31 /pmc/articles/PMC7112744/ /pubmed/32294666 http://dx.doi.org/10.11606/s1518-8787.2020054001887 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Alcantara, Geisy de Carvalho
Coutinho, Evandro Silva Freire
Faerstein, Eduardo
Pattern evolution of antidepressants and benzodiazepines use in a cohort
title Pattern evolution of antidepressants and benzodiazepines use in a cohort
title_full Pattern evolution of antidepressants and benzodiazepines use in a cohort
title_fullStr Pattern evolution of antidepressants and benzodiazepines use in a cohort
title_full_unstemmed Pattern evolution of antidepressants and benzodiazepines use in a cohort
title_short Pattern evolution of antidepressants and benzodiazepines use in a cohort
title_sort pattern evolution of antidepressants and benzodiazepines use in a cohort
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112744/
https://www.ncbi.nlm.nih.gov/pubmed/32294666
http://dx.doi.org/10.11606/s1518-8787.2020054001887
work_keys_str_mv AT alcantarageisydecarvalho patternevolutionofantidepressantsandbenzodiazepinesuseinacohort
AT coutinhoevandrosilvafreire patternevolutionofantidepressantsandbenzodiazepinesuseinacohort
AT faersteineduardo patternevolutionofantidepressantsandbenzodiazepinesuseinacohort